(NewsDirect)
Tissue Regenix Group PLC (AIM:TRX,OTC:TSSNF) chief executive Danny Lee and chief financial officer DavidCocke visit Proactive's London studio to speak with Thomas Warnerafter releasing final results for 2022.
They explain why they believe 2022 was a"transformational" year for the Group, before looking ahead towhat investors can expect next.
Leesays that Tissue Regenix is "in the process of getting theregulatory approvals" to enable it to sell its products in marketsbeyond the US.
Contact Details
Proactive UKLtd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.